279 related articles for article (PubMed ID: 33364539)
1. Biologically active compounds from marine organisms in the strategies for combating coronaviruses.
Zaporozhets TS; Besednova NN
AIMS Microbiol; 2020; 6(4):470-494. PubMed ID: 33364539
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.
Rahman MM; Islam MR; Shohag S; Hossain ME; Shah M; Shuvo SK; Khan H; Chowdhury MAR; Bulbul IJ; Hossain MS; Sultana S; Ahmed M; Akhtar MF; Saleem A; Rahman MH
Environ Sci Pollut Res Int; 2022 Jul; 29(31):46527-46550. PubMed ID: 35507224
[TBL] [Abstract][Full Text] [Related]
3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
4. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
[TBL] [Abstract][Full Text] [Related]
5. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
6. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
He C; Qin M; Sun X
Acta Pharm Sin B; 2020 Jul; 10(7):1175-1191. PubMed ID: 32834948
[TBL] [Abstract][Full Text] [Related]
7. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
8. A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2.
Guguloth SK; Lakshmi AR; Rajendran R; Rajaram K; Chinnasamy T; Huang JD; Zhang H; Senapati S; Durairajan SSK
Curr Drug Targets; 2022; 23(8):818-835. PubMed ID: 34636297
[TBL] [Abstract][Full Text] [Related]
9. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
[TBL] [Abstract][Full Text] [Related]
10. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
11. Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
Bhattacharyya P; Biswas SC
Front Microbiol; 2020; 11():571553. PubMed ID: 33072032
[TBL] [Abstract][Full Text] [Related]
12. Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans.
Yu S; Chen K; Fang L; Mao H; Lou X; Li C; Zhang Y
Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34199384
[TBL] [Abstract][Full Text] [Related]
13. Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
Orhan IE; Senol Deniz FS
Nat Prod Bioprospect; 2020 Aug; 10(4):171-186. PubMed ID: 32529545
[TBL] [Abstract][Full Text] [Related]
14. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
15. Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.
Kilianski A; Baker SC
Antiviral Res; 2014 Jan; 101():105-12. PubMed ID: 24269477
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
[TBL] [Abstract][Full Text] [Related]
17. A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective.
Rabaan AA; Alahmed SH; Bazzi AM; Alhani HM
J Med Microbiol; 2017 Sep; 66(9):1261-1274. PubMed ID: 28855003
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
19. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
[TBL] [Abstract][Full Text] [Related]
20. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.
Wang N; Shang J; Jiang S; Du L
Front Microbiol; 2020; 11():298. PubMed ID: 32265848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
